Sentences with phrase «developing innovative therapies»

«Our findings offer a promising approach for developing innovative therapies for inflammatory joint diseases as well as for treating osteoporosis, which is often suffered by women after the menopause.

Genzyme, for example, is committed to developing innovative therapies for diseases such as malaria and sleeping sickness that have largely disappeared in the industrial nations but affect millions in Third World countries.

By capitalizing on partnerships with first - class research organizations, Ipsen will strengthen its links with the medical and scientific community so as to develop innovative therapies tailoring the needs and expectations of patients and physicians.»

The focus of Memorial Sloan Kettering's Ludwig Center for Cancer Immunotherapy is to explore and develop innovative therapies that act by stimulating or strengthening the immune system's inherent ability to fight cancer.

According to Doherty, who developed the innovative therapy for the Minnesota Couples on the Brink Project, many marriage counselors discover during the first session that divorce is already being discussed.

Not exact matches

Biosimilars» burgeoning popularity has fostered some intriguing partnerships as companies try to create new, innovative biologic therapies, defend their existing products from sales slumps, and develop biosimilars to eat into competitors» branded biologics sales.

For his part, Collins, who has led NIH since 2009 and been kept on by the Trump administration, pointed to an array of promising NIH activities, including the development of new technologies to provide insights into human brain circuitry and function through the Brain Research through Advancing Innovative Neuroethologies (BRAIN initiative) and the use of the gene - editing tool CRISPR - Cas9 to correct mutations and clear the way to develop and test a «curative therapy» for the first molecular disease: sickle cell disease.

Biogen Idec (NASDAQ: BIIB) is a biotechnology leader that discovers, develops and delivers innovative therapies to improve the lives of patients with neurodegenerative diseases, autoimmune diseases and hemophilia.

Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.

The researchers from Bochum and Erlangen now plan to employ the gained insights to develop innovative dietary add - on therapies to established immunotherapies in multiple sclerosis.

Inserm researchers at the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem — Inserm / French Muscular Dystrophy Association [AFM] / University of Évry Val d'Essonne [UEVE]-RRB-, in collaboration with CNRS and Paris - Descartes University, have developed an innovative approach to study the differentiation of human stem cells and thus produce many types of cells in an optimal manner.

The strategy developed by research teams and development of I - Stem aims to identify innovative therapies applicable to rare genetic diseases based on exploring the potential offered by human pluripotent stem cells.

With the aim of pioneering a safe, effective gene therapy approach, St. Jude scientists have spent years developing an innovative vector for X-linked SCID.

Paris, France, April 3, 2018, 5.35 pm CET — GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA - PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced topline results from the REVERSE Phase III clinical trial evaluating the safety and efficacy of a single intravitreal injection of GS010 (rAAV2 / 2 - ND 4) in 37 subjects whose visual loss due to 11778 - ND4 Leber Hereditary Optic Neuropathy (LHON) commenced between 6 and 12 months prior to study treatment.

Calico, a company whose mission is to harness advanced technologies to increase understanding of the biology that controls human lifespan, and UC San Francisco have partnered on an innovative project to develop potential therapies for cognitive decline.

Wyss researchers are developing innovative new engineering solutions for healthcare, energy, architecture, robotics, and manufacturing that are translated into commercial products and therapies through collaborations with clinical investigators, corporate alliances, and formation of new startups.

Diabetes Forecast highlighted ViaCyte's first - of - a-kind islet cell replacement therapy in an article discussing twelve innovative products being developed to treat and manage type 1 diabetes.

He has received international recognition for developing innovative nutritional therapies to treat autoimmune, inflammatory, allergic, infectious and gastrointestinal disorders and has described his work in numerous scientific articles and textbook chapters.

Over the last 25 years he has developed innovative methods for healing the mind - body - spirit through eye therapy and provides individuals with natural alternatives for reducing disease and improving vitality.

Preparing for adulthood • Planning for young people's futures • A broad range of education and learning opportunities: Wolf Review • Employment opportunities and support: the role of disability employment advisers • A coordinated transition to adult health services: joint working across all services • Support for independent living Services working together for families • Local authorities and local health services will play a pivotal role in delivering change for children, young people and families • Reducing bureaucratic burdens on professionals • Empowering local professionals to develop collaborative, innovative and high quality services • Supporting the development of high quality speech and language therapy workforce and educational psychology profession • Encouraging greater collaboration between local areas • Extending local freedom and flexibility over the use of funding • Enabling the voluntary and community sector to take on a greater role in delivering services • Exploring a national banded funding framework • Bringing about greater alignment of pre 16 and post 16 funding arrangements

Pulmatrix, Inc. (PULM) From The Konlin Letter Pulmatrix, Inc. (PULM) is a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease.

He continues to develop his wealth of knowledge by adding new and innovative treatments to his practice, becoming widely respected and regarded in the field of Avian and Exotic Pet Medicine, especially in the field of Holistic Therapy.

Developed by aesthetician Kerry Benjamin, StackedSkincare ™ takes her innovative approach to skin therapy from her spa to products you can use at home.

Possess hands - on expertise in therapy, developing and implementing innovative and sophisticated departments that meet financial and service goals and consistently exceed patient expectations.

Discernment Counseling is an innovative short - term therapy that was developed by William J. Doherty, Ph.D., to treat couples where one spouse is «leaning out» of the relationship by considering divorce, while the other spouse is «leaning in» by wanting to work on the marriage, and helping those mixed - agenda couples gain clarity and confidence about a direction for their relationship.

His current research focuses on developing, testing, and implementing innovative forms of therapy for patients with personality disorders.

Schema therapy is an innovative, integrative therapeutic approach, originally developed (by Dr. Jeffrey Young) as an expansion of traditional cognitive - behavioral treatments.

«Radically open dialectical behavior therapy (RO DBT) is a truly innovative treatment, developed through translation of neuroscience into clinical practice, integrating various influences from dialectical behavior therapy (DBT), mindfulness - based approaches, emotion, personality and developmental theory, evolutionary theory, and Malamati Sufism.

She is invested in developing innovative ways to translate science - into - practice and continues to do research and education on dissemination of ACT and other therapies.

In 2008, Hron and her team developed Head Start Trauma Smart, an innovative program that evidence - based trauma therapy into Head Start classrooms.

Mindfulness - Based Cognitive Therapy (MBCT) was first developed in 2002 by Zindel Segal, Mark Williams and John Teasdale as an innovative approach to prevent relapse in patients with histories of major depression.